Generics BulletinHBW InsightIn VivoMedtech InsightPink SheetScrip

Generics Bulletin

Medtech Insight

Raptiva PML Case Brings Another REMS

Oct 17 2008

• By Randall Osborne

Related Content

PML Reported In Raptiva User; Genentech Sends “Dear Doctor” Letter

Oct 03 2008

FDA Still Behind Tysabri Monotherapy

Aug 25 2008

Tysabri Could Return In Fall; Marketing Suspended By Biogen Idec And Elan

Feb 28 2005

Tysabri Continues Comeback; On Pace To Reach 100,000 Patients In 2010

Jul 22 2008

Additional Topics

BioPharmaceutical

More from Archive

More from Pink Sheet

Twitter feed RSS feed RSS feed

About UsOpens in new window
Meet the TeamOpens in new window
RSS FeedOpens in new window

Contact Us
Customer Service
Subscribe
AdvertisingOpens in new window
Feedback

Terms and ConditionsOpens in new window

Privacy PolicyOpens in new window